BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25279712)

  • 1. Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin.
    Mentrikoski MJ; Wendroth SM; Wick MR
    Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):635-41. PubMed ID: 25279712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
    Gokden N; Gokden M; Phan DC; McKenney JK
    Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
    Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
    Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
    Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.
    Sangoi AR; Karamchandani J; Kim J; Pai RK; McKenney JK
    Adv Anat Pathol; 2010 Nov; 17(6):377-93. PubMed ID: 20966644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma.
    Prayson RA; Chamberlain WA; Angelov L
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):422-8. PubMed ID: 20453815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin.
    Ozcan A; Zhai Q; Javed R; Shen SS; Coffey D; Krishnan B; Truong LD
    Arch Pathol Lab Med; 2010 Aug; 134(8):1121-9. PubMed ID: 20670131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
    Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
    Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
    Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX2 and PAX8: useful markers for metastatic effusions.
    Waters L; Crumley S; Truong L; Mody D; Coffey D
    Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas.
    Pan Z; Grizzle W; Hameed O
    Am J Clin Pathol; 2013 Sep; 140(3):410-8. PubMed ID: 23955461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.
    Sangoi AR; Fujiwara M; West RB; Montgomery KD; Bonventre JV; Higgins JP; Rouse RV; Gokden N; McKenney JK
    Am J Surg Pathol; 2011 May; 35(5):678-86. PubMed ID: 21490444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
    Peat TJ; Edmondson EF; Miller MA; DuSold DM; Ramos-Vara JA
    Vet Pathol; 2017 Jul; 54(4):588-594. PubMed ID: 28346124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: diagnostic Implications.
    Bakshi N; Kunju LP; Giordano T; Shah RB
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):310-5. PubMed ID: 17721277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role Of Immunohistochemistry In Subtyping Renal Cell Carcinomas With Overlapping Morphological Features.
    Tariq N; Mamoon N; Haroon A; Ali Z; Ahmad IN
    J Ayub Med Coll Abbottabad; 2018; 30(3):325-332. PubMed ID: 30465359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal-cell adenocarcinoma by fine-needle aspiration biopsy.
    Simsir A; Chhieng D; Wei XJ; Yee H; Waisman J; Cangiarella J
    Diagn Cytopathol; 2005 Jul; 33(1):3-7. PubMed ID: 15945081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study.
    Mazal PR; Stichenwirth M; Koller A; Blach S; Haitel A; Susani M
    Mod Pathol; 2005 Apr; 18(4):535-40. PubMed ID: 15502805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases.
    Sangoi AR; McKenney JK; Brooks JD; Bonventre JV; Higgins JP
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):451-3. PubMed ID: 22495365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.